We are live on ! Find out more
IFAM

Institutional & Family Asset Management Portfolio holdings

AUM $654M
1-Year Est. Return 12.29%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+12.29%
3 Year Est. Return
+18.97%
5 Year Est. Return
+64.31%
10 Year Est. Return
AUM
$463M
AUM Growth
-$12.4M
Cap. Flow
-$91.8M
Cap. Flow %
-19.83%
Top 10 Hldgs %
33.36%
Holding
903
New
54
Increased
167
Reduced
209
Closed
47

Sector Composition

Rank Sector Weight
1 Technology 8.21%
2 Financials 7.83%
3 Industrials 7.4%
4 Healthcare 7.13%
5 Energy 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICI icon
751
VICI Properties
VICI
$28.7B
$2K ﹤0.01%
109
VIG icon
752
Vanguard Dividend Appreciation ETF
VIG
$114B
$2K ﹤0.01%
14
WST icon
753
West Pharmaceutical
WST
$24.7B
$2K ﹤0.01%
13
XBI icon
754
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$2K ﹤0.01%
24
-66
-73% -$5.63K
ZM icon
755
Zoom
ZM
$31.1B
$2K ﹤0.01%
+18
New +$1.48K
LGF.B
756
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$2K ﹤0.01%
182
EVBG
757
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2K ﹤0.01%
+17
New +$1.34K
IMGN
758
DELISTED
Immunogen Inc
IMGN
$2K ﹤0.01%
706
TWNK
759
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$2K ﹤0.01%
+140
New +$1.88K
BKI
760
DELISTED
Black Knight, Inc. Common Stock
BKI
$2K ﹤0.01%
27
EVOP
761
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$2K ﹤0.01%
52
SAIL
762
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$2K ﹤0.01%
80
+36
+82% +$816
ARNA
763
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2K ﹤0.01%
34
PFPT
764
DELISTED
Proofpoint, Inc.
PFPT
$2K ﹤0.01%
20
WMGI
765
DELISTED
Wright Medical Group Inc
WMGI
$2K ﹤0.01%
57
+17
+43% +$519
CCMP
766
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$2K ﹤0.01%
22
+10
+83% +$1.13K
GHDX
767
DELISTED
Genomic Health, Inc.
GHDX
$2K ﹤0.01%
35
MDSO
768
DELISTED
Medidata Solutions, Inc.
MDSO
$2K ﹤0.01%
26
WAGE
769
DELISTED
WageWorks, Inc.
WAGE
$2K ﹤0.01%
35
HZNP
770
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2K ﹤0.01%
69
MFGP
771
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$2K ﹤0.01%
77
+2
+3% +$53
ZGNX
772
DELISTED
Zogenix, Inc.
ZGNX
$2K ﹤0.01%
40
DOC
773
DELISTED
PHYSICIANS REALTY TRUST
DOC
$2K ﹤0.01%
90
BHVN
774
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2K ﹤0.01%
41
ACAD icon
775
Acadia Pharmaceuticals
ACAD
$5.09B
$1K ﹤0.01%
+38
New +$971

Similar funds

Institutional & Family Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Institutional & Family Asset Management held 903 positions worth $463M, down 2.6% from $475M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Institutional & Family Asset Management withdrew a net $91.8M in Q2 2019, closing 47 positions and reducing 209 holdings. Its most notable exit was Western Midstream Partners, an estimated $831K position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 8.2% a quarter earlier, followed by Financials and Industrials.

Against the trend, Institutional & Family Asset Management opened a new position in iShares Core International Aggregate Bond Fund worth $388K.

  • Institutional & Family Asset Management's largest Q2 2019 buy was iShares Core International Aggregate Bond Fund: 7,121 shares worth $388K.
  • Institutional & Family Asset Management added most to Core Alternative Capital in Q2 2019, an estimated $2.81M increase.
  • Institutional & Family Asset Management's biggest Q2 2019 reduction was iShares US Real Estate ETF, cutting an estimated $4.81M.
  • Institutional & Family Asset Management fully exited Western Midstream Partners in Q2 2019, selling an estimated $831K.
  • Institutional & Family Asset Management's ten largest holdings make up 33% of its $463M portfolio in Q2 2019.
  • Institutional & Family Asset Management opened 54 new positions and closed 47 in Q2 2019.
  • Institutional & Family Asset Management's portfolio value fell 2.6% quarter-over-quarter to $463M.

Based on Institutional & Family Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.